Tag:

Spinal Modulation

Latest Headlines

Spinal Modulation snags $30M in Series D

June 15, 2011

Menlo Park, CA-based Spinal Modulation has completed its $30 million Series D financing with Medtronic joining existing investors DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe

MORE EVENTS

Press Releases

Featured Jobs

Quality Assurance Specialist Job
Yoh - Lexington, MA, USA
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US
Director, Regulatory Affairs
Tesaro - Waltham, MA
Director, Public Relations Job
Celgene Corporation - Summit, NJ, US
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA

Spinal Modulation

Latest Headlines

Latest Headlines